Telomere length predicts poststroke mortality, dementia, and cognitive decline.
OBJECTIVE
Long-term cognitive development is variable among stroke survivors, with a high proportion developing dementia. Early identification of those at risk is highly desirable to target interventions for secondary prevention. Telomere length in peripheral blood mononuclear cells was tested as prognostic risk marker.


METHODS
A cohort of 195 nondemented stroke survivors was followed prospectively from 3 months after stroke for 2 years for cognitive assessment and diagnosis of dementia and for 5 years for survival. Telomere lengths in peripheral blood mononuclear cells were measured at 3 months after stroke by in-gel hybridization. Hazard ratios for survival in relation to telomere length and odds ratios for dementia were estimated using multivariate techniques, and changes in Mini-Mental State Examination scores between baseline and 2 years were related to telomere length using multivariate linear regression.


RESULTS
Longer telomeres at baseline were associated with reduced risk for death (hazard ratio for linear trend per 1,000 bp = 0.52; 95% confidence interval, 0.28-0.98; p = 0.04, adjusted for age) and dementia (odds ratio for linear trend per 1,000 bp = 0.19; 95% confidence interval, 0.07-0.54; p = 0.002) and less reduction in Mini-Mental State Examination score (p = 0.04, adjusted for baseline score).


CONCLUSIONS
Telomere length is a prognostic marker for poststroke cognitive decline, dementia, and death.
Martin-Ruiz
Carmen
C
Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom.
Dickinson
Heather O
HO
Keys
Barbara
B
Rowan
Elise
E
Kenny
Rose Anne
RA
Von Zglinicki
Thomas
T